Nucleic Acid Therapeutics Market to Reach USD 13.86 Billion by 2031 Fueled by Genetic Disorder Treatments and R&D Investments

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nucleic Acid Therapeutics Market - (By Technology (RNA targeted therapeutics, Gene Therapies, Epigenetic and microRNA modulating therapies, Genome editing therapies, Others), By Application (Autoimmune Disorders, Genetic Disorders, Infectious Diseases, Cancer, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Nucleic Acid Therapeutics Market is valued at US$ 4.93 billion in 2023, and it is expected to reach US$ 13.86 billion by 2031, with a CAGR of 13.8% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2548

Nucleic acid therapeutics represent a rapidly evolving segment of modern medicine, utilizing therapeutic DNA and RNA molecules to prevent, treat, and manage a broad range of diseases. The market is poised for substantial growth, fueled by increased research and development initiatives aimed at enhancing healthcare systems globally in response to the rising incidence of chronic diseases and genetic disorders. Advancements in biological therapies and DNA-based interventions, coupled with growing demand for innovative pharmaceutical solutions and healthcare services, are further accelerating the expansion of this sector.

Despite the positive outlook, several challenges may temper market growth. These include the high cost of nucleic acid-based therapies, a shortage of skilled professionals with expertise in advanced molecular techniques, and reliance on outdated technological infrastructure in some regions. Nevertheless, the growing emphasis on personalized medicine-where treatments are tailored to an individual's genetic profile-is driving heightened interest in nucleic acid therapeutics. In addition, increased investment by pharmaceutical companies in the development of RNA- and DNA-based therapies, rapid market adoption, and rising global healthcare demand are expected to support the continued advancement and commercialization of these therapies in the years ahead.

List of Prominent Players in the Nucleic Acid Therapeutics Market:
• Novartis
• Moderna Inc
• BioNTech
• Arrowhead Pharmaceuticals
• Merck
• Thermo Fischer Scientific
• Sanofi
• Alnylam Pharmaceuticals
• Sarepta Therapeutics
• Qiagen
• Imugene
• Copernicus Therapeutics Inc.
• Protagonist Therapeutics
• Arbutus Biopharma
• Agilent Technologies
• Silence Therapeutics (UK),
• Astellas Pharma Inc. (Japan),
• CureVac SE (Germany),
• Sirnaomics (US),
• Arcturus Therapeutics Inc. (US)
• Other Market Players

Market Dynamics:
Drivers-
The increasing prevalence of genetic disorders, including cystic fibrosis, muscular dystrophy, and various types of cancer, which often present significant treatment challenges, is driving demand for nucleic acid therapeutics. The expedited advancement of drug discovery and development is being supported by substantial investments in research and development from pharmaceutical companies, government agencies, and academic institutions. Additionally, government initiatives aimed at fostering drug innovation have facilitated a streamlined regulatory approval process and established favorable market conditions, which are expected to further propel industry growth in the coming years.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

Market Challenges
The growth of the nucleic acid therapeutics market is impeded by several critical challenges. Foremost among these is the high cost of research, development, and manufacturing, which limits patient access due to the significant financial burden associated with these advanced therapies. The complexity of nucleic acid-based treatments also presents considerable technological challenges, particularly in terms of delivery systems, stability, and scalability. Moreover, new entrants face substantial barriers related to stringent regulatory frameworks and lengthy approval processes. Limited awareness and understanding of these therapies among both healthcare providers and the general public further hinder broader adoption, posing an additional constraint on market expansion.

Regional Trends
North America is projected to lead the global nucleic acid therapeutics market in terms of revenue, supported by a strong compound annual growth rate (CAGR) over the forecast period. This growth is largely attributed to the increasing prevalence of chronic conditions such as cancer and diabetes, rising demand for targeted and personalized treatment options, and robust governmental support for cutting-edge medical innovations. Europe also represents a key market, driven by substantial investment in research and development activities that have advanced gene therapy applications and addressed the rising burden of disease. Furthermore, factors such as growing disposable income, population growth, and ongoing improvements in healthcare infrastructure are expected to reinforce market development across the region.

Recent Developments:
• In April 2024, Arrowhead Pharmaceuticals, Inc. announced the dosing of its investigational RNA interference (RNAi) therapeutic, ARO-CFB, in a Phase 1/2a clinical trial. The trial included up to sixty-six healthy volunteers and patients with complement-mediated kidney disease.
• In Aug 2022, Merck and Orna Therapeutics entered into a collaboration agreement to jointly explore, create, and market various initiatives, such as vaccines and treatments, in the fields of infectious disease and oncology.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2548

Segmentation of Nucleic Acid Therapeutics Market-
By Technology-
• RNA Targeted Therapeutics
• Gene Therapies
• Epigenetic and microRNA Modulating Therapies
• Genome Editing Therapies
• Others
By Application-
• Autoimmune Disorders
• Genetic Disorders
• Infectious Diseases
• Cancer
• Others
By End-User-
• Hospitals & Clinics
• Academic & Research Institutes
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/nucleic-acid-therapeutics-market/2548

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.